![John Curnutte](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 33 377 $ in data 30/06/2026
John T.
Curnutte was the founder of Sagimet Biosciences, Inc., founded in 2007, where he served as Chief Executive Officer from 2007 to 2010.
Dr. Curnutte currently serves as Independent Director at Pliant Therapeutics, Inc. since 2017 and as Director at Autobahn Labs, Inc. Former jobs included Chief Executive Officer at Sagimet Biosciences, Inc. from 2008 to 2010; Senior Director at Genentech, Inc. in 2000; Independent Director at Diadexus, Inc. from 2015 to 2016; Independent Non-Executive Director at Orchard Therapeutics Plc from 2019 to 2024; Co-President and EVP-Research & Development at Portola Pharmaceuticals LLC in 2018; President at Schering-Plough Biopharma in 2008; Member-Medical Staff at Stanford University School of Medicine from 1993 to 2013; Senior Advisor at Samsara BioCapital LLC; and Senior Vice President-Discovery Research at Schering-Plough Research Institute.
Education includes a doctorate from Harvard Medical School conferred in 1973 and an undergraduate degree from Harvard University conferred in 1980.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/06/2026 | 29.278 ( 0,05% ) | 33 377 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/08/2017 |
Autobahn Labs, Inc.
 Autobahn Labs, Inc. Medical/Nursing ServicesHealth Services Operates labs | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Direttore/Membro del Consiglio | 24/01/2024 |
| PORTOLA PHARMACEUTICALS, INC. | Presidente | 01/08/2018 |
| DIADEXUS, INC. | Direttore/Membro del Consiglio | 01/06/2016 |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2013 |
| SAGIMET BIOSCIENCES INC. | Amministratore Delegato | 01/03/2010 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Provides pharmaceutical research | Health Technology |
Schering-Plough Biopharma
 Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research services | Commercial Services |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Diadexus, Inc.
 Diadexus, Inc. Medical SpecialtiesHealth Technology Develops and commercializes patent-protected in vitro diagnostic products | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Finance |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Autobahn Labs, Inc.
Autobahn Labs, Inc. Medical/Nursing ServicesHealth Services Operates labs | Health Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
